ANIK vs NFLX · rev $62.2M vs P/E 25, rev $12.56B
Anika Therapeutics Inc (ANIK) versus Netflix Inc (NFLX) — a side-by-side from cached financials, not a winner call.
Anika Therapeutics Inc (ANIK) is a drug manufacturers - specialty & generic company listed on US.
Netflix Inc (NFLX) is a entertainment company listed on NASDAQ.
Latest reported ANIK revenue for 2026-06-30 was $62.2M. Net income was -$1.7M. ANIK currently screens at market cap $161.3M.
Latest reported NFLX revenue for 2026-06-30 was $12.56B. Net income was $3.40B. Revenue was up 2.5% from 2026-03-31 to 2026-06-30. NFLX currently screens at market cap $324.06B and trailing P/E 24.8.
ANIK currently screens at market cap $161.3M. NFLX currently screens at market cap $324.06B and trailing P/E 24.8.
Not investment advice. Open the ANIK and NFLX stock pages for the full models.
Not investment advice.